Navigation Links
Genedata Screener Global User Group Meetings Will Examine Advancements in Plate-based Screening
Date:9/4/2013

Basel, Switzerland (PRWEB) September 04, 2013

Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that four Genedata Screener User Group Meetings will be held in Asia, Europe, and North America during September 2013. Annual global meetings bring together scientists, lab heads, bioinformaticians, and research IT managers from leading pharmaceutical and biotechnology companies, academic institutions, and contract research organizations. With more than half of the top 25 pharmaceutical companies using Genedata Screener, industry experts from AstraZeneca, Eli Lilly, and Vertex Pharmaceuticals will be among the featured speakers who represent a growing community of researchers who run screening experiments for Compound Combination, Ion Channel, high-throughput screening, high-content screening, and label-free data analysis.

“Genedata Screener User Group Meetings underscore one of the core values at Genedata – namely that of collaboration,” said Dr. Othmar Pfannes, CEO of Genedata. “They provide real-life opportunities for Screener users to meet their peers, learn, share experiences, and discover more applications for Genedata Screener. This level of global collaboration fuels continuous technology innovations from Genedata.”

The 2013 Genedata Screener User Group Meetings will also feature Best Practice sessions on topics such as “Feature Selection in HCS Assays” and “Compound Profiling with Hit Profiler.” Meetings will be held in: Tokyo, Japan (Sept. 3); Basel, Switzerland (Sept. 10); Boston, MA (Sept.17); and San Francisco, CA (Sept. 19). Inquiries may be sent to: ugm(at)genedata(dot)com.

About Genedata
Genedata transforms
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Genedata Screener Extends Support for High-Throughput Thermofluor Assays
2. Genedata at ESACT Announces Expansion Into Biopharma Process Development
3. New Genedata Expressionist for Mass Spectrometry Showcases at 2013 ASMS
4. AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization
5. Genedata Biologics for Biopharma R&D at Ninth Annual PEGS
6. Genedata Screener 11 with Compound Combination Screening and Collaboration in the Cloud Announced at Bio-IT World 2013
7. Genedata Enables Research to Improve Personalized Treatment of Breast and Ovarian Cancer
8. Genedata Expressionist for Mass Spectrometry Showcased at 2013 Biotherapeutics Analytical Summit
9. Ono Pharmaceutical Selects Genedata Expressionist for Mass Spectrometry
10. Genedata Biologics 3.0 Boosts Efficiency Through Standardization
11. Genedata Screener Adopted for all Plate-based Screening by Major Pharmas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... 27, 2014 First articles ... Elsevier , a world-leading provider of ... pleased to announce the launch of a new journal: ... The launch of Extreme Mechanics Letters ... the forefront of applied sciences such as micro and ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 2014 ... is a professional and in-depth research report on ... information, like its definition, classification, application, and industry ... report covers the international market analysis, including China’s ... the US, Europe, Asia, China, Japan etc. regions) ...
(Date:11/26/2014)... , Nov. 26, 2014 The ... from a survey of European physicians at the ... Innovation and Biological Therapies" at the Spanish Ministry ... hosted by EuropaBio and the Spanish Bioindustry Association ... Health, physicians from Spanish oncology and rheumatology societies, ...
(Date:11/26/2014)... 2014 SonaCare Medical, a leading ... devices, recently participated in the American Urology Association’s ... .” Key opinion leaders in urology presented on ... small renal masses while attendees had the opportunity ... in hands-on labs. Attendees at the Los Angeles, ...
Breaking Biology Technology:Elsevier Announces the Launch of a New Journal: Extreme Mechanics Letters 2Elsevier Announces the Launch of a New Journal: Extreme Mechanics Letters 3Ammonium Bifluoride Market International Analysis of Manufacturing, Technology & Trends Now at ReportsnReports.com 2Ammonium Bifluoride Market International Analysis of Manufacturing, Technology & Trends Now at ReportsnReports.com 3ASBM Presents European Physicians Survey at Spanish Ministry of Health 2SonaCare Medical Supports American Urology Association’s Small Renal Mass 360° Summit 2SonaCare Medical Supports American Urology Association’s Small Renal Mass 360° Summit 3
... Nov. 3 /PRNewswire-FirstCall/ - AEterna Zentaris Inc.,(NASDAQ: ... focused on,endocrine therapy and oncology, today reported that ... for its Phase 2 trial in endometrial,cancer with ... doxorubicin. The decision to enter the second stage ...
... Nov. 3 Portola,Pharmaceuticals, a biopharmaceutical company ... cardiovascular and inflammatory,diseases, and cancer, today announced ... large Phase II clinical trial of betrixaban, ... for stroke prevention in patients with,atrial fibrillation ...
... placebo controlled Phase 2, clinical trial indicate statistically significant reduction in ... ... CDAD, PRINCETON, N.J. and JAMAICA PLAIN, Mass., Nov. 3 /PRNewswire-FirstCall/,-- ... of the University of Massachusetts Medical School (UMMS) today,announced that a ...
Cached Biology Technology:AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Endometrial Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 2AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Endometrial Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 3AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Endometrial Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 4AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Endometrial Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 5Portola Pharmaceuticals Initiates Phase II Trial of Betrixaban, its Novel Oral Factor Xa Inhibitor for Stroke Prevention in Atrial Fibrillation 2Portola Pharmaceuticals Initiates Phase II Trial of Betrixaban, its Novel Oral Factor Xa Inhibitor for Stroke Prevention in Atrial Fibrillation 3Portola Pharmaceuticals Initiates Phase II Trial of Betrixaban, its Novel Oral Factor Xa Inhibitor for Stroke Prevention in Atrial Fibrillation 4Medarex and Massachusetts Biologic Laboratories Announce Primary Objective Achieved in Phase 2 Trial of Monoclonal Antibody Combination for the Treatment of Clostridium difficile Associated Diarrhea (CDAD) 2Medarex and Massachusetts Biologic Laboratories Announce Primary Objective Achieved in Phase 2 Trial of Monoclonal Antibody Combination for the Treatment of Clostridium difficile Associated Diarrhea (CDAD) 3Medarex and Massachusetts Biologic Laboratories Announce Primary Objective Achieved in Phase 2 Trial of Monoclonal Antibody Combination for the Treatment of Clostridium difficile Associated Diarrhea (CDAD) 4Medarex and Massachusetts Biologic Laboratories Announce Primary Objective Achieved in Phase 2 Trial of Monoclonal Antibody Combination for the Treatment of Clostridium difficile Associated Diarrhea (CDAD) 5Medarex and Massachusetts Biologic Laboratories Announce Primary Objective Achieved in Phase 2 Trial of Monoclonal Antibody Combination for the Treatment of Clostridium difficile Associated Diarrhea (CDAD) 6
(Date:11/18/2014)... Nov. 17, 2014   News ... collaborate to develop The Partners Data Lake, an ... Partners Data Lake will allow researcher and clinicians ... treatment and the lives of patients , ... clinical activities across the Partners system, breaking down ...
(Date:11/11/2014)... 2014  Forensicon, Inc., a Chicago ... announce the promotion of Yaniv Schiff from ... In Schiff,s new role as Director, he will lead ... forensics examiners and provide leadership within the company,s digital ... http://photos.prnewswire.com/prnh/20141110/157719 Schiff joined Forensicon in ...
(Date:11/6/2014)... Fla. -- A groundbreaking paper from a team of ... understanding of how plants could adapt to and survive ... research, published in the latest issue of the journal ... chromatin (the complex of DNA and proteins) is organized ... so that some genes are turned on and others ...
Breaking Biology News(10 mins):Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5Yaniv Schiff Promoted to Director of Digital Forensics at Forensicon, Inc. 2Maize analysis yields whole new world of genetic science 2
... homeowners out in their yards, busily attempting to control ... weed-free lawns. Dandelions, broadleaf perennial plants that have a ... most patient gardener reach for chemical weed killers to ... answer to an environmentally responsible way to control dandelions ...
... Researchers in Australia are developing diversionary tactics to fool ... responsible for major gut infections, such as cholera, produce ... complex sugar receptors displayed on the surface of cells ... for General Microbiology,s meeting at Heriot-Watt University, Edinburgh, today ...
... A study that tracked genetic mutations through the human equivalent ... that oxidative DNA damage is a primary cause of the ... a leading cause of aging, cancer and other diseases. ... Academy of Sciences , also indicated that natural selection is ...
Cached Biology News:Organic weed control for dandelions 2Designing probiotics that ambush gut pathogens 2Study of huge numbers of genetic mutations point to oxidative stress as underlying cause 2Study of huge numbers of genetic mutations point to oxidative stress as underlying cause 3
... Agencourt offers SNP loci identification ... includes automated assay design, intensive assay ... sequencing of Corriell or customer-supplied samples ... Discovery service provides for rapid and ...
... delivers enhanced statistics and statistical interpretation ... improvement managers. As an accepted organizational ... simplifies statistics for novice users and ... experts. It offers a powerful JMP ...
... Microarray plates are ideal for use as source ... handling applications (down to 5µl). These plates are ... design. Features 384 round ... 70µl well volume (cylindrical well), 55µl well ...
... formulated for mounting tissue specimens, cell smears, ... immunohistochemical methods for viewing by light microscopy. ... such as AEC, that are alcohol-soluble or ... when slides are cover-slipped forming a coating ...
Biology Products: